Mendez‐Figueroa 2013.

Trial name or title	Frequency of blood glucose monitoring in patients with GDM (GLIMPSE)
Methods	Randomised controlled trial
Participants	Women with GDM diagnosed using ACOG criteria; between 20‐32 weeks gestation; singleton pregnancies; not requiring medical therapy after the first weeks of blood glucose monitoring
Interventions	Intervention group: blood glucose monitoring every other day as per below Control group: blood glucose monitoring done every day (during a fasting state and 2 hours after breakfast, lunch and dinner) continued throughout gestation.
Outcomes	Primary outcome: neonatal weight Secondary outcome: macrosomia
Starting date	May 2013
Contact information	Hector Mendez‐Figueroa: Hector.R.Mendezfigueroa@uth.tmc.edu The University of Texas Health Science Center, Houston, USA
Notes	Recruitment target: 286 women